Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Frequency Therapeutics revenue
Frequency Therapeutics's revenue is $2.3 million.
What is Frequency Therapeutics's revenue?
- Frequency Therapeutics's revenue growth from 2019 to 2024 is -92.15%.
- Frequency Therapeutics has 83 employees, and the revenue per employee ratio is $27,361.
- Frequency Therapeutics's peak quarterly revenue was $24.2M in 2019(q3).
- Frequency Therapeutics peak revenue was $37.0M in 2020.
- Frequency Therapeutics annual revenue for 2021 was 14.1M, -61.96% growth from 2020.
- Frequency Therapeutics annual revenue for 2024 was 2.3M, -83.86% growth from 2021.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Frequency Therapeutics historical revenue
Frequency Therapeutics's peak revenue was $37.0M in 2020. The peak quarterly revenue was $24.2M in 2019(q3).
Frequency Therapeutics's revenue increased from $28.9m in 2019 to $2.3M currently. That's a -92.15% change in annual revenue.
Frequency Therapeutics annual revenue
Frequency Therapeutics annual revenue over time
| Fiscal year / year | Frequency Therapeutics revenue |
|---|---|
| 2019 | $28.9M |
| 2020 | $37.0M |
| 2021 | $14.1M |
| 2024 | $2.3M |
How accurately did Frequency Therapeutics' revenue projections match actual performance?
Frequency Therapeutics annual growth
Frequency Therapeutics saw the greatest revenue growth in 2020, when revenue increased by 27.76%.
Frequency Therapeutics had the lowest revenue growth in 2021, when revenue changed by -61.96%.
Frequency Therapeutics annual growth rate over time
| Year | Frequency Therapeutics growth |
|---|---|
| 2020 | 28%↑ |
| 2021 | -62%↓ |
| 2024 | -84%↓ |
Frequency Therapeutics quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Frequency Therapeutics quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | - | - | $24.2M | $4.7M |
| 2020 | $7.3M | $8.5M | $11.2M | $10.0M |
| 2021 | $4.7M | $9.4M | - | - |
Frequency Therapeutics jobs nearby
Do you work at Frequency Therapeutics?
Is Frequency Therapeutics transparent about its revenue structure?
Frequency Therapeutics financial information
| CEO | David L. Lucchino |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 83 |
| Date Founded | 2015 |
| Headquarters | Woburn, Massachusetts |
| Number of Locations | 3 |
| Revenue | $2.3M |
| Net Income | -$81,580,000 |
| Tax Rate | -0.0% |
| Total Assets | $121,238,000 |
| Ticker | FREQ |
Frequency Therapeutics jobs you might like
Frequency Therapeutics financing
Frequency Therapeutics received early financing of $32.0M on 2017-04-11.
| Series | Round size | Date |
|---|---|---|
| Series A | $32M | 04/2017 |
| Grant | $2M | 05/2018 |
| Series B | $42M | 01/2019 |
| Series C | $62M | 07/2019 |
| Post Ipo Equity | $42.3M | 07/2020 |
Frequency Therapeutics investors
| Investors | Security type |
|---|---|
| Cobro Ventures Inc | Series A |
| Emigrant Capital | Series A |
| Rivas Capital LLC | Series A |
| Morningside Group | Series A |
| ALEXANDRIA REAL ESTATE EQUITIES, INC. | Series A |
| Korea Investment Partners | Series A |
| United States Department of Defense | Grant |
| Cobro Ventures Inc | Series B |
| Emigrant Capital | Series B |
| Rivas Capital LLC | Series B |
| Taiwania Capital | Series B |
| Alexandria Venture Investments | Series B |
| Korea Investment Partners | Series B |
| Cobro Ventures Inc | Series C |
| RTW INVESTMENTS LP | Series C |
| Rivas Capital LLC | Series C |
| Polaris Founders Capital | Series C |
| Mizuho Securities Principal Investment | Series C |
| Deerfield | Series C |
| Perceptive Advisors | Series C |
| Taiwania Capital | Series C |
| Deerfield Capital Management | Series C |
| Axil Capital | Series C |
| RTW INVESTMENTS LP | Post Ipo Equity |
| Maven Investment Partners US | Post Ipo Equity |
| Federated Kaufmann Fund | Post Ipo Equity |
| Perceptive Advisors | Post Ipo Equity |
| Wasatch Advisors | Post Ipo Equity |
| Alexandria Venture Investments | Post Ipo Equity |
| DRIEHAUS CAPITAL MANAGEMENT LLC | Post Ipo Equity |
Frequency Therapeutics competitors
Frequency Therapeutics's top competitor, Nurix, earned an annual revenue of $54.5M.
Frequency Therapeutics's smallest competitor is Onconova Therapeutics with revenue of $226.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Nurix | - | $54.5M | 103 | - |
| Tetralogic Pharmaceuticals | - | - | 20 | - |
| Cognition Therapeutics | - | $19.5M | 30 | - |
| Panacos Pharmaceuticals | - | - | 20 | - |
| Rigel Pharmaceuticals | - | $179.3M | 158 | - |
| Onconova Therapeutics | - | $226,000 | 12 | - |
| PTC Therapeutics | - | $806.8M | 517 | - |
| eFFECTOR Therapeutics | - | $42.0M | 24 | - |
| Annexon | - | $284.9K | 46 | - |
| Optherion | - | $610,000 | 3 | - |
Frequency Therapeutics revenue FAQs
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Frequency Therapeutics highest paying jobs
Zippia gives an in-depth look into the details of Frequency Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Frequency Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Frequency Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Frequency Therapeutics. The data presented on this page does not represent the view of Frequency Therapeutics and its employees or that of Zippia.
Frequency Therapeutics may also be known as or be related to FREQUENCY THERAPEUTICS, INC., Frequency Therapeutics and Frequency Therapeutics, Inc.